Want to see NL:LKFT full AI Analyst Report?
LKFT Stock Chart & Stats
€24.70
-€0.26(-1.07%)
At close: 4:00 PM EST
€24.70
-€0.26(-1.07%)
Day’s Range― - ―
52-Week Range€22.62 - €32.74
Previous CloseN/A
VolumeN/A
Average Volume (3M)132.01K
Market Cap
€1.77B
Enterprise Value€1.52B
Total Cash (Recent Filing)€2.98B
Total Debt (Recent Filing)€6.43M
Price to Earnings (P/E)3.6
Beta0.72
Next Earnings
Aug 10, 2026EPS Estimate
-0.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.39
Shares Outstanding65,897,070
10 Day Avg. Volume76,560
30 Day Avg. Volume132,014
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.57
Price to Sales (P/S)1.66
P/FCF Ratio-8.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€22.75Price Target Upside-7.89% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering2
EPS Forecast (FY)-2.8
Revenue Forecast (FY)€23.87M
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetGalapagos' near-zero leverage and large equity base create durable financial flexibility, allowing management to fund R&D, support operations or pursue strategic initiatives without immediate refinancing. This conservatism materially reduces insolvency risk and preserves optionality over the next several quarters.
Improved ProfitabilityTTM margins moving to ~47% net and ~51% EBIT reflect a meaningful improvement in core earnings power and operating leverage. Sustained high margins give the company room to invest in growth and R&D while improving the likelihood of converting operating gains into durable earnings over a 2–6 month horizon if revenue stabilizes.
Very High Gross MarginsConsistently high-90% gross margins indicate strong product-level economics and pricing power, which are structural advantages. They create a buffer to absorb SG&A or R&D fluctuations and support sustainable operating margins, enabling longer-term profitability resilience even with variable top-line performance.
Bears Say
Persistent Cash BurnNegative OCF and FCF across periods show the business is not self-funding and is burning cash materially. This persistent cash outflow forces reliance on the balance sheet or external capital, which constrains strategic flexibility and raises financing risk if market access tightens over the medium term.
Uneven Revenue MomentumA TTM revenue decline after prior sharp growth indicates inconsistent demand or timing of sales, complicating planning and R&D ROI assessment. Top-line volatility undermines confidence that improved margins will translate into stable free cash flow, raising execution risk for the next several quarters.
Historical Earnings VolatilityDespite recent ROE improvement (~16%) and profits, a history of earnings swings means gains may be reversible if pipeline setbacks or market shifts occur. This elevates forecast uncertainty and makes durable margin and earnings improvements less certain without consistent revenue and cash generation.
Galapagos News
LKFT FAQ
What was Galapagos’s price range in the past 12 months?
Galapagos lowest stock price was €22.62 and its highest was €32.74 in the past 12 months.
What is Galapagos’s market cap?
Galapagos’s market cap is €1.77B.
When is Galapagos’s upcoming earnings report date?
Galapagos’s upcoming earnings report date is Aug 10, 2026 which is in 31 days.
How were Galapagos’s earnings last quarter?
Galapagos released its earnings results on May 06, 2026. The company reported €0.21 earnings per share for the quarter, beating the consensus estimate of -€0.815 by €1.025.
Is Galapagos overvalued?
According to Wall Street analysts Galapagos’s price is currently Overvalued.
Does Galapagos pay dividends?
Galapagos does not currently pay dividends.
What is Galapagos’s EPS estimate?
Galapagos’s EPS estimate is -0.7.
How many shares outstanding does Galapagos have?
Galapagos has 65,897,070 shares outstanding.
What happened to Galapagos’s price movement after its last earnings report?
Galapagos reported an EPS of €0.21 in its last earnings report, beating expectations of -€0.815. Following the earnings report the stock price went down -4.224%.
Which hedge fund is a major shareholder of Galapagos?
Currently, no hedge funds are holding shares in NL:LKFT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Galapagos
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
LKFT Stock 12 Month Forecast
Average Price Target
€22.75
▼(-7.89% Downside)
Technical Analysis
Options Prices
Currently, No data available
---